drugset / Trial / NCT02865824
Polypectomy in Patients Taking Dual Antiplatelet Agents
RandomizedParallel-groupOpen-labelTreatment
Summary
Current guidelines recommend discontinuation of antiplatelets (i.e clopidogrel) for 7 days in patients taking DAT (dual antiplatelet therapy) before colonoscopy and polypectomy. The purpose of this study was to examine if a) discontinuation of these drugs reduces bleeding risks during polypectomy and if b) discontinuation of these drugs increases the occurence of thromboembolic events.
Timeline
- Start
- 2016-01
- Primary completion
- 2018-12
- Completion
- 2019-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clopidogrel | Small molecule | — | — |
| Subject | Prasugrel | Small molecule | — | — |
| Subject | Ticagrelor | Small molecule | — | — |